Recent Finacing
Recent Raise
Clinical-stage medical device company developing graphene-based, ~10µm implantable neural interfaces with AI-driven neural decoding and micrometric modulation for personalized adaptive neuromodulation in Parkinson’s, epilepsy, stroke rehabilitation and neuropsychiatric indications.
